In-house product
Flavoxate is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis and urethrocystitis.
n/a
Flavoxate is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Gastrointestinal: Nausea, vomiting, dry mouth.CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness.Hematologic: Leukopenia (which is reversible upon discontinuation of the drug).Cardiovascular: Tachycardia and palpitation.Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia.Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.
Adults and children over 12 years of age: 100 mg to 200 mg 3 times a day. With improvement of symptoms, the dose may be reduced.Pediatric Use: Safety and effectiveness in children below the age of 12 years have not been established.
n/a
Pregnancy Category B. This drug should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Caution should be exercised when flavoxate is administered to a nursing woman.
Flavoxate should be given cautiously in patients with suspected glaucoma
n/a
BPH/ Urinary retention/ Urinary incontinence
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
n/a
Flavoxate acts as a direct antagonist at muscarinic acetylcholine receptors in cholinergically innervated organs. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder, effectively reducing the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.
n/a
Login or Registerto submit your questions to seller
No none asked to seller yet